Physician
Oncology
Dr. Ragini Kudchadkar, MD
Doctor Ragini Kudchadkar, MD is an expert in the field of Oncology. He went to Emory University School of Medicine. Emory University School of Medicine is ranked 23 in research and 42 in primary care medicine Ragini Kudchadkar is also a published doctor. He has 29 publication published. The most recent publication is: Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal... He accepts Medicare.
Publications
- Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal...
- BRAF inhibition for advanced locoregional BRAF V600E mutant Melanoma: a potential neoadjuvant strategy.
- BRAF and MEK inhibition in Melanoma.
- Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic Melanoma.
- The Impact of Neoadjuvant Hedgehog Inhibitor Therapy on the Surgical Treatment of Extensive Basal Cell Carcinoma.
- Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid Tumors.
- A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV Melanoma.
- Effect of selumetinib vs chemotherapy on progression-free survival in uveal Melanoma: a randomized clinical trial.
- Melanoma, version 4.2014.
- Recent developments in the medical and surgical treatment of Melanoma.
- Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type Melanoma.
- New targeted therapies in Melanoma.
- Recent advances in the treatment of Melanoma.
- Emergence of a squamous cell carcinoma phenotype following treatment of metastatic Basal cell carcinoma with vismodegib.
- Melanoma, Version 2.2013: Featured Updates to the NCCN Guidelines.
- Targeted therapy in Melanoma.
- Ipilimumab administration for advanced Melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series.
- Integrating molecular biomarkers into current clinical management in Melanoma.
- Current and planned multicenter trials for patients with primary or metastatic Melanoma.
- Ipilimumab.
- Novel targeted therapies for the treatment of metastatic Melanoma.
- Adjuvant Immunotherapy and Radiation in the Management of High-risk Resected Melanoma.
- Adjuvant interferon: recommit or move on?
- Adjuvant therapy for Melanoma: a surgical perspective.
- Systemic treatments for merkel Cell carcinoma.
- The absent-minded professor: an unusual complication of Melanoma.
- PI-88: a novel inhibitor of angiogenesis.
- A case of Merkel Cell carcinoma.
Schools
Emory UniversityInternal Medicine
University Of Colorado Health Sciences CenterHematologyOncology
Emory University In Atlanta Ga Neuroscience and Behavioral Biology
Procedures Preformed
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Accepts most major Health Plans. Please contact our office for details.
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access
- Group Plan PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Options PPO
Education
-
University of Colorado
-
Emory University
-
Emory University School of Medicine
Hospital
-
Tampa General Hospital
-
Emory University Hospital
Drug Facts
| NPI NUMBER |
|
1982750667 |
| NPPES Provider LastName |
|
KUDCHADKAR |
| NPPES Provider FirstName |
|
RAGINI |
| NPPES Provider ZIPCode |
|
336129416 |
| NPPES Provider State |
|
FL |
| Specialty Description |
|
Hematology/Oncology |
| Total Claim Count |
|
412.0 |
| Distinct Opioid Count |
|
3.0 |
| Opioid Claim Count |
|
74.0 |
| Percent Opioid Claims |
|
17.96 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1982750667 |
| Last Name Of The Provider |
KUDCHADKAR |
| First Name Of The Provider |
RAGINI |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
This doctor has more publications